- Previous Close
1.170 - Open
1.170 - Bid 1.050 x --
- Ask 1.190 x --
- Day's Range
1.170 - 1.170 - 52 Week Range
0.990 - 1.520 - Volume
40,000 - Avg. Volume
8,852 - Market Cap (intraday)
468M - Beta (5Y Monthly) 0.35
- PE Ratio (TTM)
-- - EPS (TTM)
-0.000 - Earnings Date Nov 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Miricor Enterprises Holdings Limited, an investment holding company, provides medical aesthetic services in Hong Kong and Mainland China. The company offers non-surgical medical aesthetic services, including energy-based and injection procedures; and treatment services, as well as prescription and dispenses medical products. It also sells skin care products, such as cleansers, toners, serums, moisturizers, eye care products, ultraviolet protection products, masks, etc. In addition, the company offers provides management, health, and beauty services; engages in the wholesale of skincare products; and owns trademarks. It provides general management services. Miricor Enterprises Holdings Limited operates medical aesthetic centers under the CosMax+, XOVE, and VITAE brand names. The company was founded in 2009 and is headquartered in Central, Hong Kong.
www.miricor.com312
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 1827.HK
View MorePerformance Overview: 1827.HK
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 1827.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 1827.HK
View MoreValuation Measures
Market Cap
468.00M
Enterprise Value
449.28M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.02
Price/Book (mrq)
3.43
Enterprise Value/Revenue
0.98
Enterprise Value/EBITDA
8.54
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.55%
Return on Assets (ttm)
-1.23%
Return on Equity (ttm)
-8.78%
Revenue (ttm)
494.26M
Net Income Avi to Common (ttm)
-12.62M
Diluted EPS (ttm)
-0.000
Balance Sheet and Cash Flow
Total Cash (mrq)
145.43M
Total Debt/Equity (mrq)
72.94%
Levered Free Cash Flow (ttm)
65.18M